Literature DB >> 13850654

Topical effect of acriflavine compounds on growth and spread of malignant cells.

H GOLDIE, M WALKER, T GRAHAM, F WILLIAMS.   

Abstract

Entities:  

Keywords:  ACRIDINES/pharmacology; NEOPLASMS/experimental

Mesh：

Substances：

Year:  1959        PMID： 13850654

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  7 in total

1.  New approach to therapy of malignant disease: prevention of metastatic growth.

Authors:  M WALKER; H GOLDIE
Journal:  J Natl Med Assoc       Date:  1962-01       Impact factor: 1.798

2.  Effect of local irrigation with proflavine hemisulfate on wounds seeded with tumor cells. An experimental study.

Authors:  S C NASH; A S KETCHAM; R R SMITH
Journal:  Ann Surg       Date:  1962-03       Impact factor: 12.969

3.  Acriflavine suppresses the growth of human osteosarcoma cells through apoptosis and autophagy.

Authors:  Jingzhang Fan; Xin Yang; Zhenggang Bi
Journal:  Tumour Biol       Date:  2014-06-25

4.  Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization.

Authors:  KangAe Lee; Huafeng Zhang; David Z Qian; Sergio Rey; Jun O Liu; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-01       Impact factor: 11.205

5.  HIF-1α- Targeting Acriflavine Provides Long Term Survival and Radiological Tumor Response in Brain Cancer Therapy.

Authors:  Antonella Mangraviti; Tula Raghavan; Francesco Volpin; Nicolas Skuli; David Gullotti; Jinyuan Zhou; Laura Asnaghi; Eric Sankey; Ann Liu; Yuan Wang; Dong-Hoon Lee; Noah Gorelick; Riccardo Serra; Michael Peters; Destiny Schriefer; Fabien Delaspre; Fausto J Rodriguez; Charles G Eberhart; Henry Brem; Alessandro Olivi; Betty Tyler
Journal:  Sci Rep       Date:  2017-11-02       Impact factor: 4.379

6.  Synergism of a novel MCL‑1 downregulator, acriflavine, with navitoclax (ABT‑263) in triple‑negative breast cancer, lung adenocarcinoma and glioblastoma multiforme.

Authors:  Anbok Lee; Hyeon-Ok Jin; Kwang Seok Kim; Sae Gwang Park; Md Masudul Haque; Hee Yeon Kim; Hana Jung; Jin Hee Park; Ilwhan Kim; Joo Yeon Song; Hye Kyoung Yoon; Hyoung Kyu Kim; Jin Han; In-Chul Park
Journal:  Int J Oncol       Date:  2021-12-16       Impact factor: 5.650

Review 7.  Acriflavine, an Acridine Derivative for Biomedical Application: Current State of the Art.

Authors:  Kinga Piorecka; Jan Kurjata; Wlodzimierz A Stanczyk
Journal:  J Med Chem       Date:  2022-08-26       Impact factor: 8.039
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.